tiprankstipranks
Trending News
More News >
Soligenix Inc (SNGX)
:SNGX
Advertisement

Soligenix (SNGX) Price & Analysis

Compare
730 Followers

SNGX Stock Chart & Stats

$1.70
-$0.10(-2.65%)
At close: 4:00 PM EST
$1.70
-$0.10(-2.65%)

Soligenix News

SNGX FAQ

What was Soligenix Inc’s price range in the past 12 months?
Soligenix Inc lowest stock price was $1.09 and its highest was $6.23 in the past 12 months.
    What is Soligenix Inc’s market cap?
    Soligenix Inc’s market cap is $16.76M.
      When is Soligenix Inc’s upcoming earnings report date?
      Soligenix Inc’s upcoming earnings report date is Nov 07, 2025 which is in 17 days.
        How were Soligenix Inc’s earnings last quarter?
        Soligenix Inc released its earnings results on Aug 14, 2025. The company reported -$0.82 earnings per share for the quarter, beating the consensus estimate of -$0.92 by $0.1.
          Is Soligenix Inc overvalued?
          According to Wall Street analysts Soligenix Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Soligenix Inc pay dividends?
            Soligenix Inc does not currently pay dividends.
            What is Soligenix Inc’s EPS estimate?
            Soligenix Inc’s EPS estimate is -0.56.
              How many shares outstanding does Soligenix Inc have?
              Soligenix Inc has 9,861,130 shares outstanding.
                What happened to Soligenix Inc’s price movement after its last earnings report?
                Soligenix Inc reported an EPS of -$0.82 in its last earnings report, beating expectations of -$0.92. Following the earnings report the stock price went up 20%.
                  Which hedge fund is a major shareholder of Soligenix Inc?
                  Currently, no hedge funds are holding shares in SNGX

                  Company Description

                  Soligenix Inc

                  Soligenix, Inc. (SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company's core sectors include biotherapeutics and public health solutions. Within biotherapeutics, it is engaged in the development of specialized drug products for oncology, inflammation, and biodefense. Soligenix's lead product candidates include SGX301, a novel photodynamic therapy for cutaneous T-cell lymphoma, and SGX942, an innate defense regulator for the treatment of oral mucositis in head and neck cancer patients.

                  Soligenix (SNGX) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Evogene
                  MetaVia
                  Silexion Therapeutics
                  Ocean Biomedical
                  Apollomics

                  Ownership Overview

                  3.95%0.30%1.21%94.22%
                  1.21% Other Institutional Investors
                  94.22% Public Companies and
                  Individual Investors

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis